Production (Stage)
AVITA Medical, Inc.
AVHHL
$1.42
-$0.01-0.70%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.59% | -5.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.59% | -5.83% | |||
| Cost of Revenue | 24.25% | -28.53% | |||
| Gross Profit | -2.76% | -1.41% | |||
| SG&A Expenses | -0.04% | -14.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.97% | -14.96% | |||
| Operating Income | -18.78% | 27.88% | |||
| Income Before Tax | -19.71% | 28.73% | |||
| Income Tax Expenses | -57.89% | 167.86% | |||
| Earnings from Continuing Operations | -19.59% | 28.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.59% | 28.49% | |||
| EBIT | -18.78% | 27.88% | |||
| EBITDA | -18.41% | 29.25% | |||
| EPS Basic | -19.11% | 28.94% | |||
| Normalized Basic EPS | -18.17% | 23.85% | |||
| EPS Diluted | -19.11% | 28.94% | |||
| Normalized Diluted EPS | -18.17% | 23.85% | |||
| Average Basic Shares Outstanding | 0.41% | 0.62% | |||
| Average Diluted Shares Outstanding | 0.41% | 0.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||